MV Capital Management’s Stantec STN Stock Holding History

MV Capital Management’s Portfolio STN Stock Details STN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$276	Buy	4 +1	+33%	+$81	﹤0.01%	1111
2026 Q1	$260	Buy	3 +1	+50%	+$94	﹤0.01%	1053
2025 Q4	$189	Buy	+2	New	+$206	﹤0.01%	1038

Other funds holding STN

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MV Capital Management's STN Position: Q2 2026 in Review

MV Capital Management increased its Stantec (STN) stake by 33% in Q2 2026, buying an estimated $81 and bringing the position to 4 shares worth $276. The position accounts for ﹤0.01% of the portfolio, ranked #1111.

MV Capital Management first reported a position in STN in Q4 2025 and has held it in 3 quarters since. 291 funds tracked by Wall St. Rank hold STN as of Q2 2026.

MV Capital Management held 4 shares of Stantec worth $276 as of Q2 2026.
MV Capital Management bought 1 Stantec share in Q2 2026, an estimated $81.
Stantec made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #1111 holding.
MV Capital Management first reported a position in Stantec in Q4 2025 and has held it in 3 quarters since.
291 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.